AI Robotics in Medicine

Scale AI and Mayo Clinic launched a collaboration to develop and deploy clinical-grade AI, using the Scale Generative AI Platform and initially focusing on three priority areas to build 'reliable, accurate, and helpful' systems.

The partners emphasize privacy and compliance, keeping data within Mayo Clinic’s secure, HIPAA-compliant environment and designing for stringent security and regulatory oversight.

Framed as practical tools for clinicians now and a base for broader innovation, the effort answers a 2025 finding that 77% of health systems see immature AI as a key adoption barrier, with leaders citing goals for 'more timely, coordinated and compassionate care' and positioning Mayo 'at the forefront of modern healthcare.'

Tracking: Medicine Robotics · AI Medicine · AI Healthcare

Geography: United States, European Union, United Kingdom, Canada, Switzerland, Germany, France, Israel, China, Japan, South Korea, India, Singapore, Boston, San Francisco Bay Area, Seattle, Minneapolis, Baltimore, Pittsburgh, Houston, London, Cambridge (UK), Oxford, Zurich, Berlin, Paris, Tel Aviv, Beijing, Shanghai, Shenzhen, Tokyo, Seoul, Toronto, Montreal

1. Scale AI, Mayo Clinic launch collaboration on clinical-grade AI

Scale AI announced a collaboration with Mayo Clinic to develop and deploy AI applications in clinical care.

The partners say the effort establishes a framework for “reliable, accurate, and helpful” systems, powered by the Scale Generative AI Platform and focused initially on three priority areas. Mayo’s AI program medical director Matthew R.

Callstrom said the goal is “more timely, coordinated and compassionate care.

” The effort emphasizes privacy and compliance, with data staying inside Mayo Clinic’s secure, HIPAA-compliant environment and systems built for stringent security and regulatory oversight.

The companies frame the projects as practical tools for clinicians now and a foundation for broader innovation, responding to a 2025 finding that 77% of health systems view immature AI tools as a key adoption barrier.

Scale AI CEO Jason Droege called Mayo “at the forefront of modern healthcare. ”

Key facts:

- Scale AI and Mayo Clinic announced a collaboration to develop and deploy clinical AI applications.

- The collaboration sets a framework for reliable, accurate, and helpful systems.

- Projects are powered by the Scale Generative AI Platform.

- Initial work focuses on three priority areas, not publicly detailed.

- Data remains within Mayo Clinic’s secure, HIPAA-compliant environment.

Why it matters: A top-tier provider linking with an AI infrastructure firm signals a push from pilots toward clinical deployment.

Emphasizing data residency within a HIPAA-compliant environment addresses one of the biggest blockers to hospital AI adoption: privacy and governance.

If the partnership delivers rigorously evaluated tools that truly support clinicians and operations, it could set a template other systems follow.

Watch for disclosure of the three priority areas, evidence of real-world performance, integration into existing clinical workflows, and how governance and regulatory oversight are operationalized.

Scale